双向性室性心动过速 1922年,Schwensen首次报道1例洋地黄中毒患者伴有双向性室性心动过速。因此,双向性室速的概念并不陌生,近年来发现双向性室速也是家族遗传性儿茶酚胺敏感性室速(CPVT)患者的特征性心电图表现。 [心电图特点] “双向性室速”这一心电学术语形象地描述了室性心动...
最大的显示ECG跑步机行使前测试(上)与静脉注射后的10毫克的verapamil(下)在一个33岁的妇女与家庭cpvt. 翻译结果5复制译文编辑译文朗读译文返回顶部 正在翻译,请等待... 相关内容 a抗生素标记基因可能使人和动物产生抗药性 The antibiotic mark gene possibly causes the human and the animal has the antibiotic nat...
Methods and results: Heart telemetry device was implanted for continues ECG recording at rest, during treadmill exercise and after epinephrine injection (0.1 mg/kg I.P). Adult CASQ2 mutant mice suffered from complex ventricular arrhythmia at rest and developed bidirectional and polymorphic ventricular ...
Resting ECG measurements can identify abnormalities in children with catecholaminergic polymorphic ventricular tachycardia RESULTS. No significant differences were detected between CPVT patients who had and did not have a cardiac arrest. Comparing the CPVT and control cohorts,... MD Fridman,T Tofighi,CPS...
(B) Representative ECG recording of CPVT in triadin KO mouse after epinephrine injection (2 mg/kg i.p.). (C) Percentage and number of mice developing CPVT in KO (n = 9/11), KO+T32 (n = 3/12), KO+T3259R (n = 4/6), KO+T32-T59R+kifunensine (n = 2/6), and KO+...
ECG示:室上性心动过速。紧急处理首选A、毛花苷C静注 B、抗心动过速起搏器 C、紧急外科手术 D、机械性刺激迷走神经 E、射频消融术 F、β受体阻滞剂 G、同步直流电复律 H、非同步直流电复律 提示 如患者诊断为预激综合征并室上性心动过速。宜选用的处理措施是A、延长旁道传导时间和不应期的药物 B、使心肌...
担任法定代表人1 担任股东0 担任高管0 所有任职企业1 作为最终受益人1 所属集团0 历史信息 曾担任法定代表人 曾担任股东 曾担任高管 所有曾任职企业 曾为最终受益人0 历史控股企业0 投资信息 控股企业0 间接持股企业0 爱企查图谱 任职全景图 股权穿透图 商业关系图 风险关注 司法解析0 失信被执行人0 限制...
The diagnosis of CPVT was based on the criteria, which, in short, required stress-induced reproducible ventricular arrhythmias in patients with a normal resting ECG and no detectable structural heart abnormalities. The diagnosis of CPVT was made either on a clinical basis or after identification of...
CPVT patients show afterdepolarizations and corresponding ECG changes. AKirsi KujalaJere PaavolaAnna LahtiKim LarssonMari PekkanenMattilaMatti ViitasaloAnnukka M. LahtinenLauri ToivonenKimmo KontulaHeikki Swan
Treatment of the CPVT3* patient with flecainide significantly reduced ventricular premature beats as determined by 24 hour holter-ECG monitoring.Conclusion:\nWe quantitatively assessed drugs targeting RyR mediated SR Ca\n2+\nleak in a CPVT3* patient with a novel TECRL mutation using iPSc-CM. ...